Hospitalization and medication use in schizophrenia patients receiving risperidone long-acting injectable or oral atypical antipsychotic medication

被引：3
|
作者：
Chue, P
Lam, A
Chandra, K
Luong, D
Camacho, F
机构：
[1] Univ Alberta, Edmonton, AB, Canada
[2] Janssen Ortho Inc, Toronto, ON, Canada
[3] McKesson Phase 4 Solut, Toronto, ON, Canada
[4] Damos Inc, Toronto, ON, Canada
来源：
VALUE IN HEALTH | 2005年 / 8卷 / 06期
关键词：
D O I：
10.1016/S1098-3015(10)67768-6
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A202 / A202
页数：1
相关论文
共 50 条
  • [21] A review of compliance, depot intramuscular antipsychotics and the new long-acting injectable atypical antipsychotic risperidone in schizophrenia
    Bhanji, NH
    Chouinard, G
    Margolese, HC
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2004, 14 (02) : 87 - 92
  • [22] DISTRIBUTION AND DETERMINANTS OF LONG-ACTING INJECTABLE ANTIPSYCHOTIC MEDICATION USE AMONG OLDER ADULTS
    Lohman, Matthew
    Verma, Mansi
    Jones, Paige
    Scott, Victoria
    Fields, Eve
    INNOVATION IN AGING, 2024, 8 : 161 - 161
  • [23] The impracticality of surgically removing intramuscular long-acting injectable antipsychotic medication
    Kim, Edward
    Gopal, Srihari
    O'Donnell, Amy
    Ramcharran, Darmendra
    Mathews, Maju
    Singh, Arun
    AMERICAN JOURNAL OF EMERGENCY MEDICINE, 2018, 36 (03): : 522 - 523
  • [24] Effects of switching to long-acting injectable risperidone from oral atypical antipsychotics on cognitive function in patients with schizophrenia
    Kim, H. -H.
    Kim, S. -W.
    Lee, J. -H.
    Lee, Y. -H.
    Yang, S. -J.
    Shin, I. -S.
    Yoon, J. -S.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2010, 13 : 224 - 224
  • [25] Effects of switching to long-acting injectable risperidone from oral atypical antipsychotics on cognitive function in patients with schizophrenia
    Kim, Sung-Wan
    Shin, Il-Seon
    Kim, Jae-Min
    Lee, Seung-Hyun
    Lee, Yo-Han
    Yang, Su-Jin
    Yoon, Jin-Sang
    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2009, 24 (07) : 565 - 573
  • [26] Medication adherence and discontinuation of long-acting injectable versus oral antipsychotics in patients with schizophrenia or bipolar disorder
    Greene, Mallik
    Yan, Tingjian
    Chang, Eunice
    Hartry, Ann
    Touya, Maelys
    Broder, Michael S.
    JOURNAL OF MEDICAL ECONOMICS, 2018, 21 (02) : 127 - 134
  • [27] Risperidone versus other atypical antipsychotic medication for schizophrenia
    William T. Carpenter
    Current Psychiatry Reports, 2000, 2 (5) : 375 - 375
  • [28] Comparison of oral atypical Antipsychotics to a long-acting injectable atypical antipsychotic in patients with bipolar disorder
    Binder, C
    Fallu, A
    Yatham, LN
    BIOLOGICAL PSYCHIATRY, 2006, 59 (08) : 203S - 203S
  • [29] Long-acting injectable risperidone for the treatment of schizophrenia
    Moeller, Hans-Juergen
    DRUGS, 2007, 67 (11) : 1541 - 1566
  • [30] Does Oral Antipsychotic Pre-Treatment Influence Outcome of a Switch to Long-Acting Injectable Risperidone in Patients with Schizophrenia?
    Schmauss, M.
    Diekamp, B.
    Gerwe, M.
    Schreiner, A.
    Ibach, B.
    PHARMACOPSYCHIATRY, 2010, 43 (02) : 73 - 80
12345